Article View: be.science
Article #340Cancer - Press review (November 19, 2011) – Revue de presse (19 novembre 2011)
From: SciMedWeb
Date: Sat, 19 Nov 2011 10:30
Date: Sat, 19 Nov 2011 10:30
167 lines
8165 bytes
8165 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press review (November 19, 2011) – Revue de presse (19 novembre 2011) Vaccines group to buy cervical cancer shot, as long as it’s cheap and countries can deliver it A global vaccines group said Thursday it was working to buy shots to protect up to 2 million women and girls in poor countries from cervical cancer. Washington Post http://www.washingtonpost.com/world/europe/vaccines-group-to-buy-cervical-cancer-shot-as-long-as-its-cheap-and-countries-can-deliver-it/2011/11/17/gIQAFwRXUN_story.html Europe Bans Airport X-Ray Scanners that U.S. Still Uses The European Commission adopted new rules Nov. 14 regarding X-ray, or backscatter, body scanners at all airports in Europe. A press release ordered members of the European Union to remove X-ray scanners from its airports to avoid risking “citizens’ health and safety.” The release does not, however, cite specific reasons for the safety concern. But the news does bring into question the continued use of the very same X-ray scanners in U.S. airports. By Frances Romero. In TIME http://newsfeed.time.com/2011/11/17/europe-bans-airport-x-ray-scanners-that-u-s-still-uses/ Side Effects May Spur Men to Drop Tamoxifen for Breast Cancer Weight gain, loss of sex drive common complaints, study finds. In U.S. News & World Report http://health.usnews.com/health-news/family-health/cancer/articles/2011/11/16/side-effects-may-spur-men-to-drop-tamoxifen-for-breast-cancer Drug Delays Prostate Cancer Spread to Bones Denosumab administered to prostate cancer patients has been found to delay the spread of cancer to the bones, according to a new study published in the Lancet. By Mikaela Conley. ABC News http://abcnews.go.com/Health/prostate-cancer-drug-delays-spread-bone/story?id=14959887 Cancer Doctors Still Not Great With Patients' Pain It remains under-recognized and under-treated, survey finds. By Jenifer Goodwin. In U.S. News & World Report http://health.usnews.com/health-news/family-health/cancer/articles/2011/11/17/cancer-doctors-still-not-great-with-patients-pain Vaccine injects fresh hope into pancreatic cancer care Pancreatic cancer is the fourth-leading cause of cancer deaths in the United States and has the lowest survival rate. A vaccine injected directly into a pancreatic tumor has shown promise as a way to keep the cancer from spreading in patients whose cancer can't be treated surgically, early results from a clinical trial in New Jersey show. By Lindy Washburn The Seattle Times http://seattletimes.nwsource.com/html/health/2016766151_panc17.html WARNING: Breast Cancer Awareness Month May Be Hazardous to Your Health The irony of Breast Cancer Awareness Month is that by the end of the month there was significantly more misunderstanding in the public about the disease. By Fran Visco. In Huffington Post http://www.huffingtonpost.com/fran-visco/limited-exposure-to-breas_b_1073489.html Ovarian cancer 'is not detectable' in the blood for years A mathematical model designed by scientists in the US indicates that ovarian cancer may not be detectable in the blood using current technology until 10 years after the disease first starts to develop. Cancer Research UK http://info.cancerresearchuk.org/news/archive/cancernews/2011-11-16-Ovarian-cancer-is-not-detectable-in-the-blood-for-years Researchers discover Achilles' heel in lethal form of prostate cancer Weill Cornell physician-scientists say this vulnerability can be attacked by a targeted drug already in clinical trials to treat other types of cancers. In EurekAlert http://www.eurekalert.org/pub_releases/2011-11/nyph-rda111111.php C’est parti pour Cancer Campus C’est la première réalisation du futur parc de recherche sur le cancer. L’inauguration, hier à Villejuif, d’une pépinière d’entreprises marque le démarrage concret de Cancer Campus. Par Christine Mateus. Dans Le Parisien http://www.leparisien.fr/val-de-marne-94/c-est-parti-pour-cancer-campus-17-11-2011-1724436.php Soupçon autour d'un médicament anticancéreux Si le laboratoire français Genopharm, filiale du groupe Alkopharma, a comme l'affirme Le Parisien commercialisé des lots périmés d'un anticancéreux pour enfants, il aura à en répondre devant la justice, a déclaré jeudi Xavier Bertrand, qui attend toutefois des clarifications sur ce dossier. Par Sophie Louet. Dans Le Point http://www.lepoint.fr/fil-info-reuters/soupcon-autour-d-un-medicament-anticancereux-17-11-2011-1397309_240.php L’interdiction du bisphénol A trop précipitée selon l’Académie de médecine Dans un rapport publié mercredi, l’Académie nationale de médecine indique regretter l’interdiction précipitée du bisphénol A (BPA), dans la mesure où aucun produit de substitution n’est proposé. Dans MaxiSciences http://www.maxisciences.com/bisph%E9nol-a/l-interdiction-du-bisphenol-a-trop-precipitee-selon-l-academie-de-medecine_art18542.html Espèce d'homme, espèce de vieux, espèce de cancer, espèce de jeune‎ A quel âge est-on vieux ? Je dirais à 55 ans, n’en déplaise aux seniors dont le narcissisme sera sans doute blessé. 55 ans, c’est l’âge de la ménopause chez les femmes mais aussi chez l’homme qui dans la force de l’âge, voit parfois son corps ou sa physiologie se modifier. Par Bernard Dugué. Agora Vox http://www.agoravox.fr/actualites/technologies/article/espece-d-homme-espece-de-vieux-104329 La médecine commence à lever le voile sur les mystères du vieillissement La médecine commence à avancer sur la possibilité de reprogrammer des cellules de centenaires en cellules souches, effaçant les outrages de l’âge et prouvant que le vieillissement est réversible. Tribune de Genève http://www.tdg.ch/actu/monde/medecine-commence-lever-voile-mysteres-vieillissement-2011-11-14 Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix – InTextoResearch – Baelen (11/2011)
Technical Details
Message-ID:
<1db016ec-b8f9-437a-8d09-d10fbf4c39a9@u6g2000vbg.googlegroups.com>Path:
arc1-ca.pugleaf.net!h5ni9173pba.0!nntp.google.com!news1.google.com!postnews.google.com!u6g2000vbg.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,565a7cecd2453822,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.15.105 with SMTP id w9mr9501818pbc.7.1321698645611;
Sat, 19 Nov 2011 02:30:45 -0800 (PST)
Path: arc1-ca.pugleaf.net!h5ni9173pba.0!nntp.google.com!news1.google.com!postnews.google.com!u6g2000vbg.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press review (November 19, 2011) – Revue de presse (19 novembre 2011)
Date: Sat, 19 Nov 2011 02:30:45 -0800 (PST)
Organization: http://groups.google.com
Lines: 167
Message-ID: <1db016ec-b8f9-437a-8d09-d10fbf4c39a9@u6g2000vbg.googlegroups.com>
NNTP-Posting-Host: 87.66.169.251
Mime-Version: 1.0
X-Trace: posting.google.com 1321698645 24859 127.0.0.1 (19 Nov 2011 10:30:45 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 19 Nov 2011 10:30:45 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: u6g2000vbg.googlegroups.com; posting-host=87.66.169.251; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: UHALERCNK
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.8.131 Version/11.11,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable